BRAINLIFE.ORG





Current Neuro-Oncology




Volume 26 Number 20
20 September 2024




Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 20, 20 September






Lim-Fat MJ, Wen PY, Touat M, Puduvalli VK, Iorgulescu JB.
MGMT promoter methylation and survival following chemotherapy for WHO grade 4 IDH-mutant astrocytoma.
Neuro Oncol. 2024 Sep 11:noae157. doi: 10.1093/neuonc/noae157. PMID: 39277807. Observational study˰ ˍ




Mareček D, Kopecká V, Matěj R, Strýček O.
Bilateral thalamic glioblastoma presenting as parkinsonism: A case report.
Parkinsonism Relat Disord. 2024 Sep 11;128:107147. doi: 10.1016/j.parkreldis.2024.107147. PMID: 39276721. Case report˰ ˍ




Hu G, Tian B, Han S, Wang S, Hacker M, Li X, Bai X.
Prognostic evaluation in recurrent glioma through 11C-Choline PET/CT imaging.
EJNMMI Res. 2024 Sep 12;14(1):84. doi: 10.1186/s13550-024-01146-x. PMID: 39266803. Observational study. ˍ




Rixe O, Villano JL, Wesolowski R, Noonan AM, Puduvalli VK, Wise-Draper TM, Curry R, Yilmaz E, Cruze C, Ogretmen B, Tapolsky G, Takigiku R.
A first-in-human phase 1 study of BXQ-350, a first-in-class sphingolipid metabolism regulator, in patients with advanced/recurrent solid tumors or high-grade gliomas.
Clin Cancer Res. 2024 Sep 12. doi: 10.1158/1078-0432.CCR-24-1721. PMID: 39264252. Interventional study˰ ˍ




*Sloan L, Sen R, Liu C, Doucet M, Blosser L, Katulis L, Kamson DO, Grossman S, Holdhoff M, Redmond KJ, Quon H, Lim M, Eberhart C, Pardoll DM, Hu C, Ganguly S, Kleinberg LR.
Radiation immunodynamics in patients with glioblastoma receiving chemoradiation.
Front Immunol. 2024 Sep 13;15:1438044. doi: 10.3389/fimmu.2024.1438044. PMID: 39346903. Observational study. ˍ




Sun Z, Feng D, Zhu R.
A case of adult medulloblastoma.
Asian J Surg. 2024 Sep 13:S1015-9584(24)01979-1. doi: 10.1016/j.asjsur.2024.08.239. PMID: 39271311. Case report. ˍ




Limon D, Amiel A, Even Haim S, Gordon N, Tschernichovsky R, Stemmer S, Gal O, Laviv Y, Kanner A, Siegal T, Yust-Katz S.
A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumor.
Neurooncol Adv. 2024 Sep 16;6(1):vdae154. doi: 10.1093/noajnl/vdae154. PMID: 39429970. Interventional study. ˍ




Reimann RR, Gramatzki D, Bink A, Hench J, Frank S, Haberecker M, Hortobagyi T, Egervari K, Merkler D, Aldape K, Weller M.
Long survival in a patient with fumarate hydratase mutation-associated glioma.
J Neuropathol Exp Neurol. 2024 Sep 16:nlae100. doi: 10.1093/jnen/nlae100. PMID: 39279228. Case report. ˍ




Hickman RA, Miller AM, Holle BM, Jee J, Liu SY, Ross D, Yu H, Riely GJ, Ombres C, Gewirtz AN, Reiner AS, Nandakumar S, Price A, Kaley TJ, Graham MS, Vanderbilt C, Rana S, Hill K, Chabot K, Campos C, Nafa K, Shukla N, Karajannis M, Li B, Berger M, Ladanyi M, Pentsova E, Boire A, Brannon AR, Bale T, Mellinghoff IK, Arcila ME.
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors.
Acta Neuropathol Commun. 2024 Sep 17;12(1):151. doi: 10.1186/s40478-024-01846-4. PMID: 39289779. Observational study. ˍ




Mencia Diez FB, Egurrola Izquierdo M, Garcia Hontoria P.
A Diagnosis of Pulmonary Metastases of Benign Meningioma Using Radial Endobronchial Ultrasound.
Open Respir Arch. 2024 Sep 17;7(1):100364. doi: 10.1016/j.opresp.2024.100364. PMID: 39493969. Case report. ˍ




Sekino Y, Sonoda Y, Shibahara I, Mizusawa J, Sasaki K, Sekita T, Ichikawa M, Igaki H, Kinoshita M, Kumabe T, Shibahara J, Ichimura K, Arakawa Y, Fukuda H; Brain Tumor Study Group (BTSG) of the Japan Clinical Oncology Group (JCOG); Narita Y.
Protocol digest of a phase III randomized trial of gross total resection versus possible resection of fluid-attenuated inversion recovery-hyperintense lesion on MRI for newly diagnosed supratentorial glioblastoma: JCOG2209 (FLAMINGO).
Jpn J Clin Oncol. 2024 Sep 17:hyae130. doi: 10.1093/jjco/hyae130. PMID: 39292165. Interventional study protocol˰ ˍ




Laetsch TW, Ludwig K, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey B, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Mhlanga J, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW.
Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D.
JCO Precis Oncol. 2024 Sep 19;8:e2400258. doi: 10.1200/PO.24.00258. PMID: 39298693. Interventional study˰ ˍ




*An S, Lin H, Zhang Y, Pang B, Yan H, Liu Y, Wang L, Wu Y, Chai R, Jia W, Wang Y.
Central nervous system dissemination in spinal cord astrocytomas: association with H3 K27M mutation.
J Neurosurg Spine. 2024 Sep 20:1-10. doi: 10.3171/2024.6.SPINE24233. PMID: 39303298. Observational study. ˍ




Ng S, Rigau V, Moritz-Gasser S, Gozé C, Darlix A, Herbet G, Duffau H.
Long-term autonomy, professional activities, cognition, and overall survival after awake functional-based surgery in patients with IDH-mutant grade 2 gliomas: a retrospective cohort study.
Lancet Reg Health Eur. 2024 Sep 20;46:101078. doi: 10.1016/j.lanepe.2024.101078. PMID: 39381547. Observational study. ˍ




Shigekawa S, Inoue A, Endo T, Muto J, Inoue T, Kanematsu R, Mitsuhara T, Umebayashi D, Mizuno M, Hida K, Kunieda T; Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan.
Optimal treatment strategy for low-grade spinal cord astrocytoma: a retrospective, multicenter analysis by the Neurospinal Society of Japan.
J Neurosurg Spine. 2024 Sep 20:1-9. doi: 10.3171/2024.5.SPINE24457. PMID: 39303310. Observational study˰ ˍ